NYSE: PBHPrestige Consumer Healthcare Inc Stock
$80.18-0.14 (-0.17%)
Updated Jul 2, 2025
PBH Price
$80.18
Fair Value Price
N/A
Market Cap
$3.96B
52 Week Low
$64.94
52 Week High
$90.04
P/E
18.56x
P/B
2.16x
P/S
3.76x
PEG
2.85x
Dividend Yield
N/A
Revenue
$1.14B
Earnings
$214.61M
Gross Margin
55.8%
Operating Margin
29.16%
Profit Margin
18.9%
Debt to Equity
0.85
Operating Cash Flow
$252M
Beta
0.49
Next Earnings
Aug 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PBH Overview
Prestige Consumer Healthcare Inc. manufactures over-the-counter health and personal care products in the U.S. and internationally. Offerings include BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. It sells its products through mass merchandisers, and drug, food, dollar, convenience, and club stores, as well as online. Prestige Consumer Healthcare was founded in 1996 and is headquartered in Tarrytown, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PBH's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Pharmaceutical
Industry Rating
B
PBH
Ranked#15 of 61
Ranked#15 of 61
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $27.94 | A | |
| $3.41 | A | |
| $8.37 | A |
Be the first to know about important PBH news, forecast changes, insider trades & much more!
PBH News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PBH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PBH ($80.18) is trading above its intrinsic value of $34.42, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PBH is good value based on its earnings relative to its share price (18.56x), compared to the US market average (31.27x)
P/E vs Market Valuation
PBH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PBH due diligence checks available for Premium users.
Valuation
PBH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
18.56x
Industry
4.27x
Market
31.27x
PBH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PBH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PBH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.16x
Industry
2.23x
PBH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PBH price to earnings growth (PEG)
For valuing profitable companies with growth potential
PBH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PBH's financial health
Profit margin
Revenue
$296.5M
Net Income
$50.1M
Profit Margin
16.9%
PBH's Earnings (EBIT) of $331.82M... subscribe to Premium to read more.
Interest Coverage Financials
PBH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.4B
Liabilities
$1.6B
Debt to equity
0.85
PBH's short-term assets ($448.33M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PBH's long-term liabilities ($1.46B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PBH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PBH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$61.8M
Investing
-$3.5M
Financing
-$11.5M
PBH's operating cash flow ($251.52M)... subscribe to Premium to read more.
Debt Coverage Financials
PBH vs Pharmaceutical Stocks
Prestige Consumer Healthcare Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.